Cline Scientific's European Method Patent for Providing a Cartilage Implant with Chondrocytes
Cline Scientific shares the certificate for the patent granted related to the StemCART project.
The application is entitled "A method of providing a cartilage implant with chondrocytes". The approved patent entered into force on the June 14, 2023. The certificate can be seen attached.
Notice of the grant of this patent was received from the EPO and a press release was sent out in April.
This European patent means that Cline's method to develop stem cells into cartilage cells is protected within EPO member states, and thus strengthened the IP protection position of the StemCART end product, which increases value when the project is later sold or out-licensed.
StemCART is an advanced therapy medical product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide. This is what orthopedic surgeon and key opinion leader Professor Mats Brittberg says about this form of treatment:
"As an orthopedic surgeon but also a researcher, I have spent more than 30 years treating patients with cartilage damage. It is now of great interest to see the new use of stem cells to produce functional cartilage for many patients. This is the next step in cartilage repair.” MD, PhD, Professor, Orthopedic surgeon Mats Brittberg.
Hear more in a short interview with Mats Brittberg here: https://www.youtube.com/watch?v=3wZ4JXqqPEw
For more information, please contact:
Hanne Evenbratt, Interim CEO and VP – Research & Development
Email: hanne.evenbratt@clinescientific.com
Phone: +46 704 88 79 23
Cline Scientific AB (publ)
Pepparedsleden 1
AstraZeneca BioVentureHub Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com
About Cline Scientific
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. Cline’s unique patented surface nanotechnology provides solutions to critical challenges for cell-based products and process in Life Science. Cline is driving two projects through to a clinical stage, StemCART - a stem cell therapy for joint repair, and CellRACE- a cancer diagnostic to predict metastasis.